TransMedics Group TMDX 深 沪
等待开盘 08-25 09:30:00 美东时间
93.60
-1.170
-1.23%
华盛通- 最 高94.52
- 今 开94.07
- 成交量 77.04万股
- 最 低 92.04
- 昨 收 94.77
- 总市值 32.46亿
- 52周最高 156.00
- 市盈率 静 19.21
- 换手率 2.22%
- 52周最低 60.105
- 委 比 11.89%
- 总股本 3467.51万
- 历史最高 177.37
- 量 比 1.20
- 振 幅 2.62%
- 历史最低 10.00
- 每 手 1
- 风险率 25.03%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | AMD、Arista Networks、Booking 、加特纳、Pinterest、科力斯、Wayfair等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Precigen"买入"评级，目标价从14美元升至18美元；HC Wainwright & Co.：维持Sophia Genetics"买入"评级，目标价从12美元升至14美元
08-06 11:36
SpaceX, Teradata, Pinterest And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures gaining around 100 points on Wednesday. Shares of Space Exploration Technologies Corp (NASDAQ:SPCX) fell sharply in pre-market trading after the company reported its first quarterly financial results as a public company. SpaceX reporte...
08-05 20:03
财报速睇 | TransMedics Group 2026财年Q2营收1.90亿美元，同比增长20.7%；归母净利润0.15亿美元，同比下滑57.9%
华盛资讯8月5日讯，TransMedics Group公布2026财年Q2业绩，公司Q2营收1.90亿美元，同比增长20.7%，归母净利润0.15亿美元，同比下滑57.9%。
08-05 07:37
财报速睇 | TransMedics Group 2026财年Q2营收1.90亿美元，同比增长21.0%；归母净利润0.15亿美元，同比下滑57.1%
华盛资讯8月5日讯，TransMedics Group公布2026财年Q2业绩，公司Q2营收1.90亿美元，同比增长21.0%，归母净利润0.15亿美元，同比下滑57.1%。
08-05 04:37
TransMedics Gr Q2 Adj. EPS $0.44 Misses $0.47 Estimate, Sales $189.948M Beat $183.635M Estimate
TransMedics Gr (NASDAQ:TMDX) reported quarterly earnings of $0.44 per share which missed the analyst consensus estimate of $0.47 by 6.38 percent. This is a 52.17 percent decrease over earnings of $0.92 per share from the same period last year. The company reported quarterly sales of $189.948 million...
08-05 04:08
美股大行评级 | 潜在涨幅3586.64%！HC Wainwright上调Enlivex目标价至80美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Enlivex"买入"评级，目标价从20美元升至80美元；Canaccord Genuity：维持Pharming Group NV Sponsored ADR"买入"评级，目标价从37美元升至38美元
08-04 11:45
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
ANDOVER, Mass., Aug. 3, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients w...
08-04 04:05
Blade Air Mobility Q2 Earnings Preview
Blade Air Mobility (SRTA) is scheduled to announce Q2 earnings results on Tuesday, August 4th, before market open. The consensus EPS estimate is -$0.02, and the consensus revenue estimate is $67.61M (...
08-04 02:40
Needham Maintains Buy on TransMedics Group, Lowers Price Target to $106
Needham analyst Mike Matson maintains TransMedics Group (NASDAQ:TMDX) with a Buy and lowers the price target from $142 to $106.
08-03 18:26
